Remove Healthcare Provider Remove Pharmaceutical manufacturing Remove Prescription
article thumbnail

MEDICAL ADHERENCE – Tapping Into Provider-Patient Bonds

PM360

Improving our collective understanding of the patient’s overall healthcare experience is necessary to effectively deliver prescription support. How can we ensure that vital prescription information reaches patients when they need it? Where and how you message HCPs and patients must synchronize with when they are engaged.

Medical 52
article thumbnail

US legislative update: takeaways for European pharma

European Pharmaceutical Review

In the current US Congressional session, Congress has focused heavily on legislation directed at reducing prescription drug prices. The new law will also require drug manufacturers to pay rebates to Medicare if they increase drug prices faster than consumer inflation. Actavis, 570 U.S. 136 (2013), [link] opinions/12pdf/12-416_m5n0.pdf.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Diversity and inclusion in oncology clinical trials

Clarify Health

With the myriad of guidance and recommendations to boost diversity and inclusion in oncology trials, , biotech and pharmaceutical manufacturers are left to interpret the criteria and implement them through tangible action. Clarify launched its real-world evidence on health disparities in 2021.

article thumbnail

Google Ads and HIPAA Compliance

Penrod

Google’s Policy Restrictions on Healthcare Advertising Google’s internal rules heavily restrict healthcare players like pharmaceutical manufacturers. For instance, pharmaceutical manufacturers can only promote prescription medicine ads in Canada, the US, and New Zealand – not anywhere else.